Matches in Wikidata for { <http://www.wikidata.org/entity/Q65390062> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65390062 description "clinical trial" @default.
- Q65390062 description "ensayu clínicu" @default.
- Q65390062 description "klinisch onderzoek" @default.
- Q65390062 description "клінічне випробування" @default.
- Q65390062 name "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 name "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 type Item @default.
- Q65390062 label "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 label "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 prefLabel "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 prefLabel "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD." @default.
- Q65390062 P1050 Q65390062-162694B5-3783-49E5-9919-04EB8322A26A @default.
- Q65390062 P1132 Q65390062-7EB09D6D-E384-44E3-91B0-5786FF6AD0F5 @default.
- Q65390062 P1476 Q65390062-34C77B4B-8B9D-4E3C-BD94-6D10F35C9916 @default.
- Q65390062 P2899 Q65390062-24912E72-B0C3-472C-BDF3-02F351DA7440 @default.
- Q65390062 P3098 Q65390062-733465F5-1171-4BC8-A160-7CC0C3D1F780 @default.
- Q65390062 P31 Q65390062-2EF420BB-BBAD-4EC9-8D48-72198A0FD1C8 @default.
- Q65390062 P580 Q65390062-E85835F2-6251-4C4C-976E-0F04C0049DCD @default.
- Q65390062 P6099 Q65390062-6EEC5F89-5F31-4AE7-B557-8EE7C134EBCF @default.
- Q65390062 P6099 Q65390062-6F55DD93-C6E9-4B65-95C4-2CA31C4ABB66 @default.
- Q65390062 P8363 Q65390062-57F64DB0-65B4-4802-A585-8F2DD12D6772 @default.
- Q65390062 P1050 Q27429789 @default.
- Q65390062 P1132 "+540" @default.
- Q65390062 P1476 "A PHASE II/III RANDOMIZED, DOUBLE-MASKED, CONTROLLED, DOSE-RANGING, MULTI-CENTER COMPARATIVE TRIAL, IN PARALLEL GROUPS, TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREAL INJECTIONS OF EYE001 (ANTI-VEGF PEGYLATED APTAMER) GIVEN EVERY 6 WEEKS FOR 54 WEEKS, IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD)" @default.
- Q65390062 P2899 "+50" @default.
- Q65390062 P3098 "NCT00321997" @default.
- Q65390062 P31 Q30612 @default.
- Q65390062 P580 "2001-05-01T00:00:00Z" @default.
- Q65390062 P6099 Q42824440 @default.
- Q65390062 P6099 Q42824827 @default.
- Q65390062 P8363 Q78089383 @default.